Revolutionary opto-acoustic technology may help physicians more accurately differentiate benign from cancerous breast masses

 Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today that it has received the CE Mark for Imagio®, a new opto-acoustic imaging system, in Europe. 550 more words